In Memoriam: Gregory B. Root
National Coverage Determination
Back to NCD List
Tumor Antigen by Immunoassay CA 19-9
CMS Policy Number: 190.30
Description: Immunoassay determinations of the serum levels of certain proteins or carbohydrates serve as tumor markers. When elevated, serum concentration of these markers may reflect tumor size and grade. This policy specifically addresses the following tumor antigen: CA19-9.
Multiple tumor markers are available for monitoring the response of certain malignancies to therapy and assessing whether residual tumor exists post-surgical therapy.
Levels are useful in following the course of patients with established diagnosis of pancreatic and biliary ductal carcinoma. The test is not indicated for diagnosing these two diseases.
These services are not covered for the evaluation of patients with signs or symptoms suggestive of malignancy. The service may be ordered at times necessary to assess either the presence of recurrent disease or the patient’s response to treatment with subsequent treatment cycles.
To review all requirements of this policy, please see:
CMS NCD listing by Chapter
Covered ICD-10 Codes.
.... and many more.
|C22.1||Intrahepatic bile duct carcinoma|
|C23||Malignant neoplasm of gallbladder|
|C24.0||Malignant neoplasm of extrahepatic bile duct|
|C24.1||Malignant neoplasm of ampulla of Vater|
|C24.8||Malignant neoplasm of overlapping sites of biliary tract|
|C24.9||Malignant neoplasm of biliary tract, unspecified|
|C25.0||Malignant neoplasm of head of pancreas|
|C25.1||Malignant neoplasm of body of pancreas|
|C25.2||Malignant neoplasm of tail of pancreas|
|C25.3||Malignant neoplasm of pancreatic duct|
Sorry, you need to login or register to view additional sections of this Medicare policy.
Click here for publications catalog.
The content and format of the following files and/or webpages are
copywritten and the property of Wheaton Partners, LLC - dba CodeMap®. All
recipients of these files agree not to distribute, reproduce and/or use the
information contained within, in any manner not expressly agreed upon by the
user and Wheaton Partners, LLC - dba CodeMap®.
All code-pairs and Medicare coverage information are compiled directly from Center for Medicare and
Medicaid Services (CMS) and Medicare Contractor coverage policies. CodeMap®
has made every reasonable effort to ensure the accuracy of the information
contained. However, the ultimate responsibility for correct
coding and claims submission lies with the provider of services. Both CMS and
Medicare contractor coverage policy information may change at any time.
CodeMap® makes no representation, warranty, or guarantee that this compilation
of coverage policy information is error-free or that the use of this information
will result in Medicare coverage and subsequent payment of claims. Final
coverage and payment of claims are subject to many factors exclusively
controlled by CMS and its contractors.